Review: Is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke?

Immunologic Research

Volumn 46, Issue 1-3, 2010, Pages 127-136

  Pauly, John L ^a   Smith, Lauren A ^a   Rickert, Michael H ^a   Hutson, Alan ^a   Paszkiewicz, Geraldine M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Chemokines; Cigarette; Cytokines; Endotoxin; Inflammation; Lipopolysaccharide; Lung; Macrophage; Tobacco

Indexed keywords

BACTERIAL TOXIN; CHEMOKINE; CIGARETTE SMOKE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

AIRBORNE PARTICLE; BACTERIAL GROWTH; CAUSAL ATTRIBUTION; CIGARETTE SMOKING; CYTOKINE PRODUCTION; DUST EXPOSURE; HEMOLYSIS; HUMAN; IMMUNE SYSTEM; MACROPHAGE; ORGANIC DUST; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TOBACCO INDUSTRY;

BACTERIAL TOXINS; HUMANS; MYCOTOXINS; PNEUMONIA; SMOKE; TOBACCO;

EID: 77949424132     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8117-6     Document Type: Review

References (70)

1. WHO Report on the Global Tobacco Epidemic. The MPOWER package. Geneva: World Health Organization; 2008. 329 pp.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-7.
3. Lawrence T. Inflammation and cancer: a failure of resolution. Trends Pharmacol Sci. 2007;28: 162-5.
4. International Agency for Research on Cancer (IARC). Overall evaluation of carcinogenicity to humans. http://monographs.iarc.fr/ENG/Classification/index. php. Retrieved on 18 May 2009.
5. van der Vaart H, Postma DS, Timens W, Ten Hacken NHT. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax. 2004;59:713-21.
6. Tzortzaki EG, Lambiri I, Vlachaki E, Siafakas NM. Biomarkers in COPD. Curr Med Chem. 2007;14:1037-48.
7. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131:1557-66.
8. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 2008;11:1-15.
9. Stämpfli MR, Anderson GP. How cigarette smoke skews immune response to promote infection, lung diseases and cancer. Nat Rev Immunol. 2009;9:377-84.
10. D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smokeinduced pulmonary inflammation in mice. Eur Respir J. 2005;26:204-13.
11. Kulkarni GS, Nadkarni PP, Cerreta JM, Ma S, Cantor JO. Short-term cigarette smoke exposure potentiates endotoxin-induced pulmonary inflammation. Exp Lung Res. 2007;33:1-13.
12. Holt GP, Bartholomaeus WK, Keast D. Differential toxicity of tobacco smoke to various cell types including those of the immune system. Aust J Exp Biol Med Sci. 1974;52:211-2114.
13. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-92.
14. Spori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:272-3.
15. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ, et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res. 2006;7:66.
16. Birrell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol. 2008;214:27-37.
17. Streck RJ, Jezewski HM, Rodriquez MI, Hurley EL, Rich GA, Pauly JL. A method for isolating human lung macrophages and observations of autofluorescent phagocytes from the lungs of cigarette smokers. J Immunol Methods. 1994;174:67-82.
18. Pauly JL, Allison EA, Hurley EL, Nwogu CE, Wallace PK, Paszkiewicz GM. Fluorescent human lung macrophages analyzed by spectral confocal laser scanning microscopy and multispectral cytometry. Microsc Res Tech. 2005;67:79-89.
19. Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. Boca Raton: CRC Press; 2009. 1784 pp.
20. Baker RR. Smoke chemistry. In: Davis DL, Nielsen MT, editors. Tobacco-production, chemistry and technology. Oxford: Blackwel; 1999. p. 398-439.
21. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391:603-13.
22. Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, White P, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;2:494-502.
23. Borgerding M, Klus H. Analysis of complex mixtures-cigarette smoke. Exp Toxicol Pathol. 2005;57(Suppl 1):43-73.
24. Morton MJ, Laffoon SW. Cigarette smoke chemistry market maps under Massachusetts Department of Public Health smoking conditions. Regul Toxicol Pharmacol. 2008;51:1-30.
25. Barsanti KC, Luo W, Isabelle LM, Pankow JF, Peyton DH. Tobacco smoke particulate matter chemistry by NMR. Magn Reson Chem. 2007;45:167-70.
26. Doz E, Noulin N, Boichot E, Guénon I, Fick L, Le Bert M, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008;180:1169-78.
27. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NFκB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol. 2007;179:6097-106.
28. Pauly JL, Waight JD, Paszkiewicz GM. Tobacco flakes on cigarette filters grow bacteria: a potential health risk to the smoker? Tob Control. 2008;17:i49-52.
29. Leulier F, Lemaitre B. Toll-like receptors-taking an evolutionary approach. Nat Rev Genet. 2008;9:165-78.
30. Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem. 2007;76:141-65.
31. Takeuchi O, Akira S. Review: signaling pathways activated by microorganisms. Curr Opin Cell Biol. 2007;19:185-91.
32. Jerala R. Structural biology of the LPS recognition. Int J Med Microbiol. 2007;297:353-63.
33. Hempling WP, Bokelman GH, Shulleeta M. US Patent 6,755,200. Method for reduction of tobacco specific nitrosamines. June 29 2004.
34. Rooney AP, Swezey JL, Wicklow DT, McAtee MJ. Bacterial species diversity in cigarettes linked to an investigation of severe pneumonitis in US Military personnel deployed in operation Iraqi freedom. Curr Microbiol. 2005;51:46-52.
35. Wiernik A, Christakopoulos A, Johansson L, Wahlberg I. Effect of air-curing on the chemical composition of tobacco. Rec Adv Tobacco Sci. 1995;21:39-80.
36. Larsson L, Szponar B, Ridha B, Pehrson P, Dutkiewicz J, Krysińska-Traczyk E, et al. Identification of bacterial and fungal components in tobacco and tobacco smoke. Tob Induc Dis. 2008;4:4. doi: 10.1186/1617-9625-4-4.
37. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest. 1999;115:829-35.
38. Larsson L, Szponar B, Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air. 2004;14:421-4.
39. Sebastian A, Pehrson C, Larsson L. Elevated concentrations of endotoxin in indoor air due to cigarette smoking. J Environ Monit. 2006;8:519-22.
40. Lane KS. US patent 6,786,221. Method and system for assay and removal of harmful toxins during processing of tobacco products. September 7 2004.
41. Subbiah V. Method of inhibiting mycotoxin production. US Patent 5,698,599. Dec 16 1997.
42. Cui M, Nielsen MT, Hart III RF, Overbey ML, Watson DJ, Chipley JR. Use of chlorate, sulfur or ozone to reduce tobacco specific nitrosamine. US Patent 2006/019516 A1. Sept 7 2006.
43. Warke RG, Kamat AS, Kamat MY. Irradiation of chewable tobacco mixes for improvement in microbiological quality. J Food Prot. 1999;62:678-81.
44. Segal BH. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist. 2007;12:7-13.
45. Walsh TJ, Roilides E, Cortez K, Kottilil S, Bailey J, Lyman CA. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Med Mycol. 2005;43:S165-72.
46. Verweij PE, Kerremans JJ, Voss A, Meis JF. Fungal contamination of tobacco and marijuana. JAMA. 2000;284:2875.
47. Philip Morris: Project clover Marlboro-roll your own report on the microbial analysis. Jan 26 1984. http://legacy.library.ucsf.edu/tid/dda29e00. Retrieved on 3 Sept 2009. 38 pp.
48. Peele DM. US Patent 6,895,974. RJ Reynolds, Tobacco processing. May 24 2005.
49. Peedin GF. Production and practices-flue-cured tobacco. In: Layten Davis D, Mark Nielsen T, editors. Tobacco: production, chemistry and technology. London: Blackwell; 1999. p. 104-228.
50. Squires WC, Hayes LE, Reynolds RJ. Tobacco flora: quantitative studies. http://tobaccodocuments.org/ rjr/500937365-7489.html. Accessed 9 Nov 1961. 125 pp.
51. Williams JR. Tobacco products having reduced nitrosamine content. US Patent RE38123. May 27 2003.
52. British American Tobacco Company (BAT). Discussion group on ends quality. http://tobacco documents.org/batco/109979765-9924.html. Accessed 2nd-4th July Aug 1 1985. 161 pp.
53. Rainer NB. Cigarettes having minimized loose ends and process for preparing same. US Patent #4,715,388, Dec 29 1987.
54. Farr WK. Revere A: examination of whole cigarette smoke by light and electron microscopy. New York: Life Extension Foundation; 1958.
55. Martonen TB, Musante CJ. Importance of cloud motion on cigarette smoke deposition in lung airways. Inhal Toxicol. 2000;12:261-80.
56. Marriott HM, Dockrell DH. The role of the macrophage in lung disease mediated by bacteria. Exp Lung Res. 2007;33:493-505.
57. Zhang Y, Chen J, Chen Y, Dong J, Wei Q, Lou J. Environmental mycological study and allergic respiratory disease among tobacco processing workers. J Occup Health. 2005;47:181-7.
58. Work-Related Lung Disease (WoRLD) Surveillance report. NIOSH-National Institute for Occupational Safety and Health. Hypersensitivity Pneumonitis. Extrinsic allergic alveolitice, Code 495. http://www2.cdc.gov/drds/ WorldReportData/.
59. Singh N, Davis GS. Review: occupational and environmental lung diseases. Curr Opin Pulm Med. 2002;8:117-25.
60. Woda BA. Hypersensitivity pneumonitis: an immunopathology review. Arch Pathol Lab Med. 2008;132:204-5.
61. Wanner A, Salathé M, O'Riordan TG. Review: mucociliary clearance in the airways. Am J Respir Crit Care Med. 1996;154:1868-902.
62. Birrell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol. 2008;214:27-37.
63. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-16.
64. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-73.
65. Kharitonov SA, Sjöbring U. Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. Contrib Microbiol. 2007;14:83-100.
66. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14-32.
67. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10.
68. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG. Advances in the biology of oral cancer. Oral Oncol. 2007;43:523-34.
69. Rubinstein I, Pederson GW. Bacillus species are present in chewing tobacco sold in the United States and evoke plasma exudation from the oral mucosa. Clin Diagn Lab Immunol. 2002;9:1057-60.
70. Arrendondo J, Chernyavski AI, Marubio LM, Beaudet AL, Jolkovsky DL, Pinkerton KE, et al. Receptor-mediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells. Am J Pathol. 2005;166:597-613.